Free Republic

With the CCP Virus pandemic having exposed scary domestic shortages of critical medical goods ranging from safety masks to ventilators, along with potential shortages of pharmaceuticals, political leaders across the spectrum are finally regretting having allowed so much output of these products to migrate offshore. China’s role in global supply chains has understandably sparked much of the alarm, since its government has all but threatened to withhold supplies of medicines whenever it wishes. But all told, at least 38 countries (including the 27-member European Union) have curbed exports of anti-pandemic products at some point since the CCP Virus began dominating...

They claim the order will harm efforts to provide doctors and hospitals with the equipment and medicines they need to stop the spread of COVID-19 The Association for Accessible Medicines (AAM), a trade association for major pharmaceutical manufacturers such as 3M, is drafting a letter to send to President Trump opposing his proposed ‘Buy American’ executive order reshoring medical supply chains. The letter currently has over 40 signatories, including PhRMA, a Big Pharma lobbying organization, dozens of medical nonprofits, and free market-oriented organizations, indicating the president will face immense pressure across the political spectrum for trying to reduce US medical...

Bringing pharmaceutical production back to the United States would create more than 800,000 American jobs, economists say. A study by the Coalition for a Prosperous America’s Steven Byers and Jeff Ferry reveals that the U.S. could add hundreds of thousands of good-paying manufacturing jobs for American citizens and reduce its dependence on foreign countries like China if it reshored all pharmaceutical production. “The US is dependent on China for over one-third of all the antibiotics we import, and in the case of many generic drugs, we are completely dependent on China,” the economists wrote. “We found that an ambitious but...